The translational potential of cholesterol-based therapies for neurological disease

Nat Rev Neurol. 2023 Oct;19(10):583-598. doi: 10.1038/s41582-023-00864-5. Epub 2023 Aug 29.

Abstract

Cholesterol is an important metabolite and membrane component and is enriched in the brain owing to its role in neuronal maturation and function. In the adult brain, cholesterol is produced locally, predominantly by astrocytes. When cholesterol has been used, recycled and catabolized, the derivatives are excreted across the blood-brain barrier. Abnormalities in any of these steps can lead to neurological dysfunction. Here, we examine how precise interactions between cholesterol production and its use and catabolism in neurons ensures cholesterol homeostasis to support brain function. As an example of a neurological disease associated with cholesterol dyshomeostasis, we summarize evidence from animal models of Huntington disease (HD), which demonstrate a marked reduction in cholesterol biosynthesis with clinically relevant consequences for synaptic activity and cognition. In addition, we examine the relationship between cholesterol loss in the brain and cognitive decline in ageing. We then present emerging therapeutic strategies to restore cholesterol homeostasis, focusing on evidence from HD mouse models.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood-Brain Barrier / metabolism
  • Brain
  • Cholesterol* / metabolism
  • Disease Models, Animal
  • Huntington Disease* / metabolism
  • Huntington Disease* / therapy
  • Mice
  • Neurons / physiology

Substances

  • Cholesterol